MMM

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

✓

Return

-2.21%

Status

scored

The analyst recommends a 25-30% trim of MMM shares into the $165.90-$167 zone, reducing residual weight to approximately 50-55% of benchmark, while implementing a protective collar hedge (long $160 puts / short $175 calls, 1-2 month tenor) to shield against Q3 FY2026 earnings risk. The bearish thesis is supported by price below all short-term moving averages, a 72% two-year FCF collapse from $5.07B to $1.4B, and macro headwinds from the zero-cut environment, with re-entry triggers at $172+ close on volume >3M with MACD bullish cross (upgrade to Hold) or capitulation washout to $130-$135 (value entry reassessment).

Outcome

✓

Return

+0.90%

Status

scored

Maintain MMM at current model weight through Q3 FY2026 earnings catalyst in late October; the fundamental bear case (28.8x TTM P/E, $9.6B net debt up $2.2B in 9 months, 437.9% D/E) is roughly balanced by the technical bull case (200 SMA $159.47 holding since March 2026, $6.35B TTM FCF at 7.6% yield, 1.9x net debt/EBITDA, RSI 40). Early-warning soft exit at $160.08 on two consecutive closes reduces position by 50%, with a reduced add trigger at $165.58 on volume >20-day average for 25% scaling; hard stop remains $159.47 close on volume >3M. Q3 earnings is the binary catalyst: upgrade to Overweight if forward EPS >$8.00 with FCF >$2.0B and PFAS charges <$200M; downgrade to Underweight if PFAS charge >$200M or forward EPS <$7.50.

Outcome

✓

Return

-0.93%

Status

scored

Execute a 25-30% Underweight trim targeting residual at 55-60% of benchmark weight, with entry at $163-165 rallies over 1-2 weeks. Implement a collar hedge (long $158 puts / short $178 calls, 1-2 month tenor) to immunize the Q3 FY2026 earnings catalyst in late October while preserving recovery optionality.

Outcome

–

Return

+0.28%

Status

scored

Execute Underweight via 35-40% trim into rallies at the $165-168 zone, reducing residual to ~50-55% of benchmark weight while implementing a collar hedge (long $160 puts / short $180 calls, 1-2 month tenor) to neutralize the Q3 earnings catalyst risk; hard stop at $159.46 (200-SMA) close on volume >3M triggers full exit.

Outcome

✓

Return

+0.80%

Status

scored

Maintain MMM at current weight through Q3 FY2026 earnings (late October) given solid FCF ($6.35B TTM, 7.6% yield) and balance sheet (1.9x debt/EBITDA), but avoid new exposure given unproven consensus EPS ($9.83 never delivered) and bearish technical structure. Use $153-154 hard stop (2x ATR below 200 SMA) and consider a partial collar (long $155-160 puts / short $180 calls) ahead of the binary Q3 catalyst; reassess at earnings with explicit upgrade/downgrade triggers tied to forward EPS and PFAS resolution.

Outcome

✓

Return

-0.69%

Status

scored

MMM is rated Underweight with a recommendation to trim 30-35% of the position into rallies at the $167.31 (10 EMA) zone over 1-2 weeks, deploying proceeds into HON/ITW/EMR over 2-4 weeks. A collar hedge (long $160 puts / short $180 calls, 1-2 month tenor) is recommended on residual, with a hard stop at $159.49 close on volume >3M triggering full exit. Price target is $160.0 with reassessment at Q3 FY2026 earnings (late October 2026).

Outcome

–

Return

-0.69%

Status

scored

Execute Underweight through a calibrated 40-45% position trim into rallies at $172.00-$173.50 (50 SMA/Bollinger upper cluster), reducing to ~50-55% of benchmark weight while implementing a collar hedge (long $160 puts funded by short $180 calls, 1-2 month tenor) ahead of Q3 FY2026 earnings; hard stop triggers at $161.41 close on volume exceeding 3M shares.

Outcome

✓

Return

-2.58%

Status

scored

Execute a 35–40% trim of MMM into rallies at the $172.69–$173.44 resistance cluster, targeting residual at ~50–55% of benchmark weight, with a hard stop at $161.41 on closing basis with volume >3M shares. Implement a collar hedge (long $160 puts financed by short $180 calls) to neutralize downside gap risk ahead of Q3 FY2026 earnings, with explicit re-entry triggers at $173.44 and downgrade triggers at $162 and $161.41.

Outcome

–

Return

-0.58%

Status

scored

Execute Underweight on MMM via 40% trim (targeting ~50% residual weight), selling into rallies at $172–173 resistance rather than chasing weakness, with a $160/$180 March 2026 collar hedge financing downside protection; hard stop exits residual fully on close below $159 (200 SMA) with volume >3M, with explicit Q3 FY2026 earnings reassessment in late October 2026.

Outcome

✓

Return

-0.04%

Status

scored

Maintain MMM at 1.0-1.25% position size with an active HOLD framework rather than fresh commitment at ~$169, implementing three execution refinements: trim 25-30% if $173-$175 is reached without volume confirmation within five sessions, simplify the buy trigger to daily close >$173.74 on >4M shares with either forward EPS revision confirmation or 10Y yield below 4.7%, and cap any breakout-add at 50% of typical sizing. Stop at $159.44 remains firm, with pre-committed triggers for add, trim, weakness, and hard exit governing the 1-3 month horizon through Q3 FY2026 earnings.

Outcome

✓

Return

+1.21%

Status

scored

Maintain MMM at HOLD with a refined MACD-line-cross entry trigger rather than a 50 SMA reclaim trigger, given the 1:1 risk/reward at $167.52 (5% upside to $172.67 resistance vs 5% downside to $158 support) which does not justify fresh capital deployment. Implement protective hedging via 1-2 month $155-160 puts (1-2% of position value) ahead of the Q3 FY2026 earnings catalyst in late October, with pre-committed reassessment triggers tied to the earnings print.

Outcome

✓

Return

-1.63%

Status

scored

Execute a 35-40% Underweight trim on MMM at $170.30, targeting a residual position of 60-65% of benchmark, with a hard stop at $160 (200 SMA zone at $159.38). Use the 50 SMA at $172.44 as a binary trigger: confirmed close above with volume >3M and 2-3 sessions follow-through → exit another 25%; bearish reversal candle on elevated volume → exit another 25%. Reassess at Q3 FY2026 earnings (late October) as the definitive catalyst.

Outcome

✓

Return

+0.59%

Status

scored

Maintain active Hold at 1.0-1.25% portfolio weight; the binding 9/21 MMM Underweight reflection overrides the trader's SELL proposal, as that call was directionally WRONG (+2.6% return against the bearish thesis), and the current price action shows bullish reversal characteristics (MACD histogram flip, RSI reset from 27 to ~50, reclaim of 10 EMA and Bollinger midline on above-average volume) arguing against fresh bearish positioning pre-Q3 earnings in late October.

Outcome

✗

Return

+2.62%

Status

scored

Execute a 20-30% Underweight trim on MMM at current $164-168 levels, targeting a residual weight of 70-80% of benchmark, with a hard stop at $158.50 (below the 200 SMA at $159.40). The three-way analyst debate converges on bearish direction, but empirical alpha ceiling constraints (-2.3% to +0.3% across six prior MMM Underweight calls) mandate the lower bound of sizing ranges rather than aggressive positioning. Reject full SELL (50% trim) and passive Hold in favor of the neutral analyst's disciplined residual management framework with explicit pre-committed triggers. Reassessment catalyst is Q3 FY2026 earnings in late October, with hard exit triggered on close below $158.50.

Outcome

✓

Return

+0.72%

Status

scored

Maintain Hold with calibrated 1-1.25% position size and active pre-committed triggers rather than passive Hold, with protective hedging ahead of late-October Q3 FY2026 earnings. The aggressive analyst's $9.78 forward EPS target leaves a 27% gap from the $7.12 annualized Q2 actuals, while the conservative analyst correctly flags thin equity cushion ($2.95B vs $12.55B debt) and unresolved PFAS exposure—neither extreme conviction fits. Add on confirmed close above $166.64 VWMA with volume >3M and positive MACD; trim 50% on break below $162; exit fully on close below $158 (200 SMA failure).

Outcome

✗

Return

+1.27%

Status

scored

Maintain Hold on MMM with 1-1.25% position sizing and hard stop at $158, balancing a genuine value case (7.6% FCF yield, 1.1x leverage, 16.6x forward P/E vs 21-24x peers) against OCF deterioration (2023: $6.68B to 2025: $2.31B), unresolved PFAS liability, and stagnant top-line. The framework is active-conditional (not pre-loaded): add on close above $162 with volume >3M and MACD contraction, exit below $158 with volume >3M, and hedge Q3 earnings via protective puts or collar given binary catalyst risk in late October.

Outcome

–

Return

-1.23%

Status

scored

Maintain Underweight on MMM with a calibrated 20-30% trim (lower bound), targeting residual exposure at 70-80% of benchmark weight. Structural deterioration is severe (FCF funding gap of ~$3.4B, negative tangible book of $(2.8B), 437% debt-to-equity), but the empirical ceiling on MMM Underweight alpha (-2.3% to +0.3% band) argues against aggressive sizing; the relief squeeze from $162 to $164.67 has already materialized. Hard stop at $158.50 (just below 200 SMA at $159.49) with full reassessment at Q4 2025 earnings (late January 2026).

Outcome

✗

Return

+1.64%

Status

scored

Maintain MMM Underweight with a 30-40% tranched trim (residual 60-70% of benchmark) at current $162 levels, scaling the remainder into any relief bounce toward the $167-$172 confluence zone over 2-4 weeks. The sizing respects the empirical alpha ceiling on MMM Underweight calls (-2.3% to +0.3% band) while honoring directional conviction broken by MACD expansion (-1.89), RSI at 29 (60-day low), and confirmed deleveraging stall with negative tangible book of -$4.48B.

Outcome

✓

Return

-1.79%

Status

scored

Maintain Underweight rating with a calibrated 30-40% trim to reduce exposure to 60-70% of benchmark weight, executing in the $167-170 zone with a hard stop at $158.50 on residual positions; do not initiate fresh shorts at current levels as the trader's $170.50 short entry is broken and shorting oversold conditions (RSI 29, lower Bollinger Band) into a binary Q3 earnings catalyst is deemed too risky.

Outcome

✗

Return

+1.30%

Status

scored

Maintain Underweight with a calibrated 25-40% trim targeting 60-75% residual benchmark weight, executed flexibly across the $165-172 zone rather than waiting for a specific bounce. Hard stop set at $158.50 (below the 200 SMA at $159.51), with re-evaluation triggered by the September 16 FOMC outcome and mid-October Q3 2026 earnings. Trimmed proceeds held in cash or short-duration Treasuries yielding approximately 5% in money market funds, preserving optionality rather than forced rotation into other industrial names.

Outcome

✓

Return

-0.94%

Status

scored

Maintain a calibrated Underweight on MMM, trimming 30-50% of positions on rallies into the $171.00-172.50 zone (50 SMA re-test) to reduce to 50-75% of benchmark weight. Target $159.49 (200 SMA test) with stop at $176.50; new shorts sized at only 25-50% of normal conviction given binary Q3 2026 earnings risk in late October and the structural significance of the 200 SMA.

Outcome

✗

Return

-1.86%

Status

scored

Maintain MMM at its current position size and do not add at the current price near $168.56, as the short-term trend is not confirmed (below the $172.60 10 EMA, MACD histogram making lower lows, and the $9.78 forward EPS assumption not yet validated). Add only after a close above $172.60 with improving MACD and RSI confirmation while Q3 FY2026 forward estimates remain at or above $9.

Outcome

–

Return

-0.62%

Status

scored

Trim 20-25% of MMM at $168.75 to reduce exposure below benchmark weight, with the hard stop on the residual 75-80% at $162 (above the 200 SMA). The technical deterioration—MACD crossing below zero with histogram at -1.92 and closed break below the lower Bollinger Band at $170.33—warrants action, but the binding empirical ceiling from six consecutive Underweight calls producing alpha only in the -2.3% to +0.3% band justifies the smaller trim size over a full exit. Re-engage on Tier 1 close >$174.65 with MACD contracting, Tier 2 capitulation flush to $157-160, or full exit below $159.45.

Outcome

✓

Return

+0.15%

Status

scored

Maintain MMM at current sizing and do not add at $168.75, as the risk/reward is approximately 1:1 with broken momentum. Hold is operationalized with two pre-committed entry triggers: Tier 1 weakness re-entry at $157–$160 zone on capitulation volume with bullish MACD divergence, or Tier 2 strength re-entry on confirmed 50 SMA reclaim ($170.92) with volume confirmation and positive MACD. Hard exit is set at $159.45 weekly close with expanding volume; re-evaluation toward Buy requires Q3 earnings confirmation of the $9.78 EPS trajectory and gross margin expansion beyond SG&A cuts.

Outcome

✓

Return

-0.26%

Status

scored

MMM is maintained at Hold with a balanced 1:1 risk/reward, as 22% YoY net-income decline, negative tangible book value, and 2025 FCF of $1.40B against $4.81B of shareholder returns create near-term risk that outweighs the forward EPS recovery thesis. The technical picture is bearish with MACD crossover, RSI falling through the 40s, and price testing the 50-day moving average, though the 200-day trend at $159.41 remains intact. Active investors should await a close above $170.54 with RSI above 50 and positive MACD histogram before adding, or trim 50–75% on a break below $159.41.

Outcome

✓

Return

-0.88%

Status

scored

Hold recommended on MMM based on binding empirical ceiling from six prior Underweight calls producing alpha of only -2.3% to +0.3%. The decision maintains current position size with a tiered risk framework: trim ~15% on $167 daily close, additional ~15% on $164 close, and full exit at $159.41 (200 SMA). Pre-committed re-entry triggers are set at $178 for trend resumption, $155-160 for capitulation flush, and Q3 2026 earnings for catalyst validation.

Outcome

–

Return

-0.93%

Status

scored

Trim 15-20% of MMM position immediately at $171.83 rather than waiting for the trader's $178-180 zone, which is now overhead resistance. Stop loss is set at $166 (below the trader's $170.33 noise-level stop), with re-entry triggers at confirmed close above $178 on volume >4M with MACD turning up, or a flush to the $159-160 zone with RSI below 30.

Outcome

✓

Return

-1.44%

Status

scored

The portfolio manager recommends an Underweight rating on MMM, trimming 15-20% of existing exposure at $174.34 to reach ~80-85% of benchmark weight, based on four aligned bearish signals (Bollinger breach, 10 EMA crossover, MACD bearish crossover with histogram at -1.23, ATR range expansion) that mirror the 8/26/8/27 empirical lessons where Hold produced -1.3% alpha leakage. A hard stop is set at $169.00 (below 50 SMA), with tiered re-entry triggers at $155-160 on weakness, $178.43 on strength reclaim, and Q3 2026 earnings as a catalyst validation point.

Outcome

✓

Return

-2.51%

Status

scored

Trim 20-25% of MMM exposure at current levels (~$178.83) to capture the directional lean from aligned bear signals without surrendering capital to execution drag. Retain ~75-80% of benchmark weight with a hard stop at $169.26 (50 SMA) on the residual core. Re-entry is pre-committed on either a confirmed breakout above $184.90 on volume >5M with MACD histogram turning positive, or a pullback to $160-170 zone with capitulation volume and positive MACD divergence.

Outcome

✓

Return

-0.65%

Status

scored

Maintain MMM at benchmark weight (1.0x) with no add and no trim pending Q3 2026 earnings catalyst. Five consecutive Underweight calls produced sub-0.3% alpha on this same setup, prompting a shift to Hold per the 8/25 reflection directive. Neither the $195+ constructive target (requires breakout confirmation) nor the $154 bear target (requires 200 SMA breakdown at ~$159) has materialized, making Hold the only position justified by the empirical record and analyst convergence.

Outcome

–

Return

+0.35%

Status

scored

Underweight rating maintained with a calibrated 25% trim at $179.37 to ~75% of benchmark weight, honoring the directional signal while respecting the empirical record of four prior Underweight calls producing sub-0.3% alpha. Pre-committed re-entry triggers are set at $172 on weakness, $184.21 on strength, or Q3 2026 earnings catalyst; hard stop at $169.26 (50 SMA) on residual core.

Outcome

–

Return

+0.20%

Status

scored

Trim 20-25% of MMM at $178.50 to lock in gains from the 28% rally off March lows, while retaining a core position (≥75% of prior weight) with a hard stop at $169.54 (50 SMA). Implement a tighter collar ($185 short call / $170 long put) aligned with technical resistance, and re-engage on three explicit triggers: trend resumption above $184.90 on elevated volume, support retest at $175.70 with MACD divergence, or Q3 2026 earnings confirming adjusted EPS ≥$1.95 with gross margin expansion.

Outcome

–

Return

+0.03%

Status

scored

Trim 25-30% of MMM exposure on rallies into the $183-$184 zone, reducing to ~70-75% of prior allocation while maintaining structural-recovery beta, with a stop at $185.50-$186 above the upper Bollinger at $185.25. Tiered re-entry conditions range from 10-EMA reclaim at $180.16 with >4M volume (Tier 1) to $175.60 retest with positive MACD histogram (Tier 2) to $169 50-SMA test with breadth confirmation (Tier 3), over a 1-3 month horizon through Q3 2026 earnings in late October.

Outcome

–

Return

+0.49%

Status

scored

Trim 35-45% of MMM exposure at $178, reducing to 55-65% of prior allocation, with a stop at $168 (50 SMA) and conditional re-entry triggers at $187.50 breakout or $160-168 pullback; full exit is rejected due to structural support at the 200 SMA ($159.51) and real FCF generation ($6.35B TTM), making Underweight the calibrated asymmetric position.

Outcome

–

Return

-1.42%

Status

scored

Maintain Underweight at 50-60% benchmark weighting on MMM at $180.66; do not initiate new longs or add at current levels. Retain a core position sized at 35-45% trim with $175 strike protective puts (Oct/Dec expiry) as hedge rather than calls, given MACD bearish cross, RSI bearish divergence, and price below 10 EMA confirming momentum reversal. Re-entry requires either forward EPS revision to ≤$8.50 confirmed by management, MACD bullish re-cross with RSI >55 and price >$184 on ≥6M volume, or favorable Watson MDL bellwether outcome; stop-loss set at $170 (lower Bollinger band).

Outcome

✓

Return

-0.15%

Status

scored

Maintain a reduced MMM position after trimming 35-45% of exposure into the $184-186 zone, with a stop at $170 and a price target of $166; while the operational turnaround (41.28% gross margin, double-digit EPS growth, raised 2026 guidance) justifies keeping roughly 50% residual, the inflated TTM FCF ($6.35B vs normalized ~$1.7B), three consecutive Watson MDL plaintiff verdicts with a "higher for longer" macro backdrop, and technically deteriorating momentum (MACD histogram at -0.59, lower high at $184) prevent a constructive rating.

Outcome

–

Return

+0.41%

Status

scored

MMM earns an Underweight rating based on damning capital return math ($1.40B returns against $763M FCF), an equity base hollowed from $14.8B to ~$3.0B with negative tangible book value (-$2.82B), and escalating litigation tail risk with 2,000+ plaintiffs remaining. The trading plan executes a measured one-third trim over 2–4 weeks into the $180–183 rebound zone, preserves a tight residual stop at $172 (above the 50 SMA, tighter than the trader's $167), and reserves full exit for a $167 close on volume above 6M confirming structural breakdown. No hedges are recommended per the 8/13 lesson showing hedge costs exceed realized protection in sideways chop.

Outcome

✓

Return

-1.34%

Status

scored

Maintain MMM at benchmark-neutral sizing ($182.65 entry) with HOLD rating as all three analysts converge correctly on the balanced view—structural momentum is intact (golden cross, 32.8% EPS growth, 20.3% margin), but near-term path to $174 is more probable than $200 given negative MACD histogram, failed RSI 70 retests, and ATR compression; trim 30-40% into any $188-190 rally while awaiting the Q3 2026 earnings binary catalyst in late October before committing incremental capital.

Outcome

–

Return

0.00%

Status

scored

Trim 50% of MMM at $183–185 to lock in the 16% one-month gain, retaining the other half with a structural stop at the 50 SMA ($166). Hedge the retained position by buying protective puts at $175 for October/December expiry instead of selling covered calls, preserving upside convexity while managing the downside risk from fading momentum and unfavorable Watson MDL litigation dynamics.

Outcome

✓

Return

-0.61%

Status

scored

Portfolio Manager maintains HOLD on MMM at $183.78 with expected value of -1.9%, rating the stock a "coin flip with negative drift." The decision favors a 0.5-1.5% position size with a $165.40 stop-loss (50 SMA) and no additions at current levels—trims 25-33% into strength at $189-191, re-enters on pullback to $175-178, or adds on confirmed breakout above $184.38 with volume exceeding 3M shares. Patience is positioned as the core strategy given 3:1 unfavorable risk/reward at current prices versus structural downside to the 50 SMA.

Outcome

✓

Return

+0.35%

Status

scored

Maintain a HOLD rating on MMM with a widened trailing stop at $172.62 (breakout retest zone), avoiding new longs above $179 and preferring re-entry at $179 for a smaller pilot position with a larger add at $176 only on declining-volume basing confirmation; upside target is $190.90 (Bollinger upper band) with $215 removed from core plan, and thesis invalidation occurs on a close below $172.62 on volume ≥6M shares.

Outcome

✓

Return

+0.60%

Status

scored

Maintain a HOLD rating with the core position protected by a hard trailing stop at $179 (10 EMA on a closing basis). Do not deploy new capital at $182, as the entry fails on three independent axes: 1:2 unfavorable risk/reward to the $164 trend line, momentum deceleration with MACD compression and RSI at 67.8, and binary CPI/PFAS catalysts in the immediate window. Await either a confirmed breakout above $184.90 on volume ≥8M shares after the CPI print clears, or a pullback into the $168-$173 zone with RSI below 55 before considering a half-sized add.

Outcome

✓

Return

-0.47%

Status

scored

Recommend trimming 25–35% of MMM exposure via 3–4 tranches over 3–5 trading days, scaling sales toward the upper Bollinger Band at $190.27, while maintaining a 65–75% core position with a hard exit below $179.50 on volume ≥6M shares; rebuild toward neutral weight in the $165–170 zone as the spin-off catalyst approaches and post-Q2 2026 earnings clarity emerges. The rating of Underweight reflects a technically overextended position with elevated RSI (~70), a 30%+ rally in ~6 weeks without pullback, and stretched valuation at 22.9–24.4x forward P/E despite modest 1.5% revenue growth and aggressive capital return funded by balance sheet compression ($4.8B returned vs. $1.4B FCF).